Table 1.

Overall assessment of combined immunotherapy tolerability

Score	Signs of intolerance
–1 point	Body temperature above 38°C for more than 24 h from initiationof combined immunotherapy
–1 point	Local and systemic skin reactions (rash, hyperemia) and/or local and systemic itching
–1 point	Presence of “new” complaints (nausea, weakness, dizziness, headaches) associated with combined immunotherapy